Literature DB >> 21717117

Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma.

Yunhong Xia1, Rongxin Chen, Sheng-Long Ye, Ruixia Sun, Jun Chen, Yan Zhao.   

Abstract

The stroma of hepatocellular carcinoma (HCC) is markedly infiltrated with activated hepatic stellate cells (HSCs), and associated invasion and metastasis of HCC. However, little is known of the role of HSCs in immune responses in HCC. The Buffalo rat HCC model was established. Quiescent HSCs (qHSCs) and intratumoral HSCs (tHSCs) were isolated. Surface molecules of tHSC were detected by flow cytometry, and gene expression was analyzed by fluorescence quantitative RT-PCR. T cell proliferation was monitored by [(3)H]-thymidine ((3)H-TdR) incorporation into DNA, and cytotoxic activity was assessed by measuring the release of (51)Cr. The level of cytokine expression by T cells was measured by enzyme-linked immunosorbent assay. T cell apoptosis was detected by double-stained terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) and anti-CD3 antibodies. The migration and invasion of HCC was observed by transwell experiments. tHSCs express low levels of major histocompatibility complex (MHC) class I, MHC class II, and costimulatory molecules, and produce varying levels of cytokines. Addition of the tHSCs suppressed thymidine uptake by T cells that were stimulated by alloantigens or by anti-CD3-mediated T-cell receptor ligation. The tHSC-induced T-cell hyporesponsiveness was associated with enhanced T-cell apoptosis, and contributed to the migration and invasion of hepatoma cell. tHSCs was associated with markedly enhanced expression of B7-H1. Blockade of B7-H1/PD-1 ligation significantly reduced HSC immunomodulatory activity, and hepatoma cell migration and invasion. tHSCs can induce T cell apoptosis, suggesting an important role for B7-H1. The interactions between tHSCs and T cells may contribute to hepatic immune tolerance and invasion and migration of HCC.

Entities:  

Mesh:

Year:  2011        PMID: 21717117     DOI: 10.1007/s10585-011-9399-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

Review 1.  Interactions between hepatic stellate cells and the immune system.

Authors:  J J Maher
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

2.  In vivo immune modulatory activity of hepatic stellate cells in mice.

Authors:  Cheng-Hsu Chen; Liang-Mou Kuo; Yigang Chang; Wenhan Wu; Christina Goldbach; Mark A Ross; Donna B Stolz; Liepin Chen; John J Fung; Lin Lu; Shiguang Qian
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

3.  The JAM test. A simple assay for DNA fragmentation and cell death.

Authors:  P Matzinger
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

4.  Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.

Authors:  Paul Hatfield; Alison E Merrick; Emma West; Dearbhaile O'Donnell; Peter Selby; Richard Vile; Alan A Melcher
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

5.  Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells.

Authors:  C O Savage; C C Hughes; R B Pepinsky; B P Wallner; A S Freedman; J S Pober
Journal:  Cell Immunol       Date:  1991-10-01       Impact factor: 4.868

6.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

7.  TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2.

Authors:  Marcelo G Binker; Andres A Binker-Cosen; Herbert Y Gaisano; Rodica H de Cosen; Laura I Cosen-Binker
Journal:  Biochem Biophys Res Commun       Date:  2011-01-08       Impact factor: 3.575

Review 8.  Roles of TGF-beta in hepatic fibrosis.

Authors:  Axel M Gressner; Ralf Weiskirchen; Katja Breitkopf; Steven Dooley
Journal:  Front Biosci       Date:  2002-04-01

9.  Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25).

Authors:  Roniel Cabrera; Miguel Ararat; Mengde Cao; Yiling Xu; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

10.  Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.

Authors:  L Lu; D McCaslin; T E Starzl; A W Thomson
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

View more
  10 in total

1.  The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma.

Authors:  Xuqi Li; Pei Li; Yuanhong Chang; Qinhong Xu; Zheng Wu; Qingyong Ma; Zheng Wang
Journal:  Mol Cell Biochem       Date:  2014-07       Impact factor: 3.396

2.  [Characteristics of peripheral rheograms following thermal provocation in normal and pathologic pregnancy].

Authors:  A Feiks; C Nowotny; W Gruber
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-09       Impact factor: 2.915

3.  MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma.

Authors:  Wei Guo; Wei Tan; Shan Liu; Xuhui Huang; Juze Lin; Ronghua Liang; Le Su; Qiao Su; Changjun Wang
Journal:  Tumour Biol       Date:  2015-06-18

Review 4.  Hepatic stellate cells: central modulators of hepatic carcinogenesis.

Authors:  Alexandra I Thompson; Kylie P Conroy; Neil C Henderson
Journal:  BMC Gastroenterol       Date:  2015-05-27       Impact factor: 3.067

Review 5.  T-cell exhaustion in the tumor microenvironment.

Authors:  Y Jiang; Y Li; B Zhu
Journal:  Cell Death Dis       Date:  2015-06-18       Impact factor: 8.469

6.  DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.

Authors:  Zhen Lu; Yun-Hong Xia; Min Zhao; Bing Zhang; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Jin-Ling Bi; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

7.  Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells.

Authors:  Xing-Qiu Liang; Jian Liang; Xiao-Fang Zhao; Xin-Yuan Wang; Xin Deng
Journal:  World J Gastroenterol       Date:  2019-03-07       Impact factor: 5.742

8.  Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.

Authors:  Yun-Hong Xia; Zhen Lu; Min Zhao; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

9.  Nrf2 activation mediates tumor-specific hepatic stellate cells-induced DIgR2 expression in dendritic cells.

Authors:  Yun-Hong Xia; Zhen Lu; Shou-Min Wang; Li-Xia Hu
Journal:  Aging (Albany NY)       Date:  2019-12-13       Impact factor: 5.682

Review 10.  Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.